Phenylbutyrate and Valganciclovir in Treating Patients With Relapsed or Refractory Epstein-Barr Virus-Positive Cancer
University of California, San Diego
University of California, San Diego
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)